Pharmacogenomics Effects on High-Dose Methotrexate Clearance in Patients With Diffuse Large B-Cell Lymphoma

NCT06031194 · clinicaltrials.gov ↗

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Central Nervous System Lymphoma
Diffuse Large B-Cell Lymphoma

Interventions

OTHER: Non-Interventional Study

Sponsor

Ohio State University Comprehensive Cancer Center